Development of an <i>in vitro</i> genotoxicity assay to detect retroviral vector-induced lymphoid insertional mutants.

Journal Information

Full Title: Mol Ther Methods Clin Dev

Abbreviation: Mol Ther Methods Clin Dev

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Medicine, Research & Experimental

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"raw and processed expression data from all experiments have been deposited in gene expression omnibus under the geo accession gse241160 ."

Code Sharing
Evidence found in paper:

"Declaration of interests The authors declare no competing interests."

Evidence found in paper:

"This work was funded by the Federal State of Lower Saxony under the “R2N - Reduce and Replace in Lower Saxony” consortium (grant agreement 74ZN1574), by the 10.13039/501100001659German Research Foundation, Germany (REBIRTH Center for Translational Regenerative Medicine through the State of Lower Saxony, MWK: ZN3440; SFB738). This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement n° 755170 (RECOMB)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025